Fuse Medical Inc (FZMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,098 | -1,588 | -1,433 | -3,317 | 3,958 |
| Depreciation Amortization | 137 | 68 | 104 | 1,039 | 50 |
| Income taxes - deferred | N/A | N/A | N/A | 761 | -431 |
| Accounts receivable | -1,886 | -64 | 649 | -1,624 | 918 |
| Accounts payable and accrued liabilities | 1,239 | 1,225 | -2,149 | 40 | -83 |
| Other Working Capital | -596 | 324 | -611 | 51 | 2,962 |
| Other Operating Activity | -1,957 | -1,743 | 3,676 | 3,044 | -4,893 |
| Operating Cash Flow | $35 | $-1,778 | $237 | $-5 | $2,480 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -21 | -15 | -42 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -63 |
| Investing Cash Flow | $0 | $0 | $-21 | $-15 | $-105 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 200 | N/A | N/A |
| Debt Issued | -436 | 2,783 | 511 | N/A | N/A |
| Debt Repayment | -5 | -736 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 11 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -913 | -839 | 275 | -2,335 |
| Financing Cash Flow | $-440 | $1,144 | $-128 | $275 | $-2,335 |
| Beginning Cash Position | 553 | 1,188 | 1,099 | 844 | 805 |
| End Cash Position | 148 | 553 | 1,188 | 1,099 | 844 |
| Net Cash Flow | $-405 | $-634 | $88 | $255 | $40 |
| Free Cash Flow | |||||
| Operating Cash Flow | 35 | -1,778 | 237 | -5 | 2,480 |
| Capital Expenditure | N/A | N/A | -21 | -15 | -42 |
| Free Cash Flow | 35 | -1,778 | 216 | -20 | 2,438 |